Factors associated with multi-drug-resistant tuberculosis in Dakar, Senegal, 2010-2016


Submitted: 22 April 2019
Accepted: 17 October 2019
Published: 20 March 2020
Abstract Views: 672
PDF: 485
HTML: 16
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Mbouna Ndiaye West Africa Field Epidemiology Training Program (WAFETP), Burkina Faso.
  • Pauline Kiswendsida Yanogo West Africa Field Epidemiology Training Program (WAFETP), and Faculty of Medicine, University Ouaga 1, Professor Joseph Ki-zerbo, Burkina Faso.
  • Bernard Sawadogo West Africa Field Epidemiology Training Programme (WAFETP), Burkina Faso.
  • Fadima Diallo West Africa Field Epidemiology Training Programme (WAFETP), Burkina Faso.
  • Simon Antara West Africa Field Epidemiology Training Programme (WAFETP), Burkina Faso.
  • Nicolas Meda West Africa Field Epidemiology Training Program (WAFETP), and 2aculty of Medicine, University Ouaga 1, Professor Joseph Ki-zerbo, Burkina Faso.

According to the World Health Organization, multidrug-resistant tuberculosis (MDR-TB) represents a major obstacle towards successful TB treatment and control. In Dakar, MDR-TB management began in 2010 with the strengthening of diagnostic resources. The objective of this study was to identify the factors associated with multidrug-resistant tuberculosis in Dakar between 2010 and 2016. We conducted a case-control study from January 10 to February 28, 2017 in tuberculosis centers in Dakar. of 169 cases and 507 controls. We used logistic regression with Epi-info version 7.2.1. to estimate the odds ratios of association. Factors significantly associated with MDR-TB were: residing in a periurban area (ORa=1.8; 95% CI (1.5-4.9); p=0.024), presence of MDR-TB in the entourage of patient (ORa=7.0; 95% CI (6.1-9.5); p=0.002), previous treatment failure (ORa=29.5; 95% CI (27.3-30.1); p=0.000), treatment not directly observed by a health care provider (ORa=4.3; 95% CI (4.1-7,2); p=0.000) and irregularity of treatment (ORa=1.7; 95% CI (0.5-5.4); p=0.037). Focusing interventions on population at-risk will prevent MDR-TB.


Ndiaye, M., Yanogo, P. K., Sawadogo, B., Diallo, F., Antara, S., & Meda, N. (2020). Factors associated with multi-drug-resistant tuberculosis in Dakar, Senegal, 2010-2016. Journal of Public Health in Africa, 10(2). https://doi.org/10.4081/jphia.2019.1099

Downloads

Download data is not yet available.

Citations